Nancy Simonian

Nancy Simonian

Chief Executive Officer at SYROS PHARMACEUTICALS, INC.

Net worth: 753 056 $ as of 2024-04-29

63 year
Health Technology
Consumer Services
Commercial Services

Network origin in Nancy Simonian first degree

EntityEntity typeIndustry
Princeton University
256
College/University Other Consumer Services 256
242
Non-Profit Organization Miscellaneous Commercial Services 242
105
Subsidiary Pharmaceuticals: Major 105
Public Company Pharmaceuticals: Major 52
Subsidiary Pharmaceuticals: Major 51
Public Company Pharmaceuticals: Major 42
Public Company Biotechnology 39
36
Foundation/Endowment Miscellaneous Commercial Services 36
Public Company Pharmaceuticals: Major 17
Subsidiary Pharmaceuticals: Major 14
Perelman School of Medicine
5
College/University Other Consumer Services 5

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Nancy Simonian via their personal network

CompanySectorRelated peopleMain position
Pharmaceuticals: Major

Mark B. Skaletsky

Katrine Bosley

Director/Board Member

Corporate Officer/Principal

ALZA CORPORATION Pharmaceuticals: Major

Rachel King

John Orwin

Corporate Officer/Principal

Sales & Marketing

AMGEN INC. Pharmaceuticals: Major

Fabrizio Bonanni

Helen Torley

William Sibold

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

BAXTER INTERNATIONAL INC. Medical Specialties

Fabrizio Bonanni

James Tobin

Chief Tech/Sci/R&D Officer

President

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Tim Tyson

Helen Torley

Jeremy Levin

James Sapirstein

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Biotechnology

Srini Akkaraju Akkaraju

Mark Levin

Jean-Jacques Bienaimé

Ted Love

David Schenkein

John Orwin

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

John Milligan

James Meyers

Ted Love

James Sapirstein

Douglas Maffei

Chief Executive Officer

Corporate Officer/Principal

Director/Board Member

Sales & Marketing

Investor Relations Contact

IMMUNOGEN, INC. Biotechnology

Daniel Junius

Mark B. Skaletsky

Daniel Char

Chief Executive Officer

Director/Board Member

General Counsel

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Felix Baker

Deborah Dunsire

Jeremy Springhorn

Director/Board Member

Director/Board Member

Corporate Officer/Principal

DYAX CORP. Pharmaceuticals: Major

Paolo Pucci

Ronald Cohen

Director/Board Member

Director/Board Member

Medical Specialties

Marsha Fanucci

Steven J. Burakoff

Jean-Jacques Bienaimé

Peter Wirth

Gerald Quirk

William Sibold

Corporate Officer/Principal

Director/Board Member

Director/Board Member

General Counsel

Corporate Officer/Principal

President

H. LUNDBECK A/S Pharmaceuticals: Major

Deborah Dunsire

Jeremy Levin

Chief Executive Officer

Director/Board Member

ULTRAGENYX PHARMACEUTICAL INC. Pharmaceuticals: Major

Deborah Dunsire

Clay Siegall

Director/Board Member

Director/Board Member

Stanford University College/University

Felix Baker

Srini Akkaraju Akkaraju

Barbara Kosacz

Yung S. Lie

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

University of Pennsylvania College/University

John Fry

Christophe M. Bianchi

Carolyn J. Fritz

Chief Operating Officer

Masters Business Admin

Masters Business Admin

TAKEDA PHARMACEUTICAL COMPANY LIMITED Pharmaceuticals: Major

Deborah Dunsire

John Maraganore

Director/Board Member

Director/Board Member

Financial Conglomerates

Margaret A. Gilliam

Leon Cooperman

Karen D. Seitz

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

AFFYMAX, INC. Biotechnology

Ted Love

John Orwin

Director/Board Member

Chief Executive Officer

University of Oxford College/University

Jeremy Levin

Stephen Hill

Alphonse Galdes

Undergraduate Degree

Doctorate Degree

Doctorate Degree

George Washington University College/University

Clay Siegall

Carolyn J. Fritz

Doctorate Degree

Graduate Degree

Biotechnology

John Milligan

James Sapirstein

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Jeremy Springhorn

Andrew Oh

Corporate Officer/Principal

Private Equity Investor

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Pyott

Marsha Fanucci

John Maraganore

Director/Board Member

Director/Board Member

Chief Executive Officer

Boston College College/University

Daniel Junius

James Meyers

Peter van Camp

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Rutgers State University of New Jersey College/University

John Orwin

James Sapirstein

Undergraduate Degree

Undergraduate Degree

The University of Chicago College/University

Jeffrey Leiden

John Maraganore

Karen D. Seitz

Doctorate Degree

Doctorate Degree

Masters Business Admin

Yale University College/University

Christopher G. Standlee

Richard Young

William Sibold

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Tufts University College/University

Vaughn M. Kailian

Daniel Char

Undergraduate Degree

Undergraduate Degree

New York University College/University

Steven J. Burakoff

John Fry

John Orwin

Corporate Officer/Principal

Masters Business Admin

Masters Business Admin

University of Illinois College/University

John Milligan

Ertharin Cousin

Doctorate Degree

Undergraduate Degree

Hospital/Nursing Management

Deborah Dunsire

John Orwin

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

James E. Hoyes

James Sapirstein

President

Corporate Officer/Principal

Pharmaceuticals: Major

Tim Tyson

Deborah Dunsire

Jean-Jacques Bienaimé

James E. Hoyes

Jean-Christophe Tellier

Mark Timney

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Carl Feldbaum

Jeremy Levin

Ted Love

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Frederic Roch Doliveux

Jean-Christophe Tellier

Corporate Officer/Principal

Director/Board Member

Miscellaneous Commercial Services

Jeremy Levin

Ronald Cohen

Director/Board Member

Chairman

BLUEPRINT MEDICINES CORPORATION Biotechnology

Mark Levin

David Schenkein

Kyle Kuvalanka

Chairman

Director/Board Member

Director of Finance/CFO

Miscellaneous Commercial Services

Mark Levin

Steven Holtzman

Rachel King

Director/Board Member

Director/Board Member

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Jean-Jacques Bienaimé

Kyle Kuvalanka

Masters Business Admin

Masters Business Admin

Harvard Business School College/University

James Tobin

Brian Atwood

Rachel King

Simon Waddington

William Sibold

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Kellogg School of Management College/University

Daniel Junius

Colleen Goggins

Andrew Oh

Graduate Degree

Graduate Degree

Masters Business Admin

The Leonard N Stern School of Business College/University

John Fry

John Orwin

Jonathan Wolfson

Masters Business Admin

Masters Business Admin

Masters Business Admin

Miscellaneous Commercial Services

James Tobin

Stephen Hill

Director/Board Member

Director/Board Member

Statistics

International

United States 46
Denmark 2
Japan 2
United Kingdom 2
France 2

Sectoral

Health Technology 27
Consumer Services 16
Commercial Services 6
Finance 3
Health Services 2

Operational

Director/Board Member 711
Corporate Officer/Principal 240
Independent Dir/Board Member 220
Chairman 157
Chief Executive Officer 138
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW